EP3152283B1 - Verfahren und vorrichtung zur schrittweisen aufarbeitung eines organischen öls - Google Patents
Verfahren und vorrichtung zur schrittweisen aufarbeitung eines organischen öls Download PDFInfo
- Publication number
- EP3152283B1 EP3152283B1 EP15727638.7A EP15727638A EP3152283B1 EP 3152283 B1 EP3152283 B1 EP 3152283B1 EP 15727638 A EP15727638 A EP 15727638A EP 3152283 B1 EP3152283 B1 EP 3152283B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- oil
- acid
- phase
- oil phase
- addition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 45
- 238000012545 processing Methods 0.000 title claims description 14
- 239000012071 phase Substances 0.000 claims description 131
- 235000021588 free fatty acids Nutrition 0.000 claims description 66
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 64
- 150000003904 phospholipids Chemical class 0.000 claims description 55
- 239000002253 acid Substances 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 239000008346 aqueous phase Substances 0.000 claims description 35
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 33
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 32
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 32
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 20
- 229930195729 fatty acid Natural products 0.000 claims description 20
- 239000000194 fatty acid Substances 0.000 claims description 20
- 150000004665 fatty acids Chemical class 0.000 claims description 20
- 239000011574 phosphorus Substances 0.000 claims description 20
- 229910052698 phosphorus Inorganic materials 0.000 claims description 20
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 19
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 239000001632 sodium acetate Substances 0.000 claims description 15
- 235000017281 sodium acetate Nutrition 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 9
- 229930182470 glycoside Natural products 0.000 claims description 7
- 150000002338 glycosides Chemical class 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 150000001341 alkaline earth metal compounds Chemical class 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 239000000470 constituent Substances 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 229910017604 nitric acid Inorganic materials 0.000 claims description 3
- 235000006408 oxalic acid Nutrition 0.000 claims description 3
- 238000007127 saponification reaction Methods 0.000 claims description 3
- 235000011054 acetic acid Nutrition 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims 1
- 239000003921 oil Substances 0.000 description 164
- 235000019198 oils Nutrition 0.000 description 164
- 238000000926 separation method Methods 0.000 description 30
- 239000010779 crude oil Substances 0.000 description 29
- 239000000126 substance Substances 0.000 description 29
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 25
- 239000000203 mixture Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 18
- 238000003860 storage Methods 0.000 description 18
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- 239000011777 magnesium Substances 0.000 description 15
- 239000000344 soap Substances 0.000 description 15
- 239000011575 calcium Substances 0.000 description 14
- 239000003925 fat Substances 0.000 description 14
- 235000019197 fats Nutrition 0.000 description 14
- 229910052742 iron Inorganic materials 0.000 description 14
- 229910052749 magnesium Inorganic materials 0.000 description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 13
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 13
- 229910052791 calcium Inorganic materials 0.000 description 13
- 241000196324 Embryophyta Species 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 12
- -1 chlorophyll Chemical compound 0.000 description 12
- 235000002639 sodium chloride Nutrition 0.000 description 12
- 238000004061 bleaching Methods 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- 240000002791 Brassica napus Species 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 229930002875 chlorophyll Natural products 0.000 description 7
- 235000019804 chlorophyll Nutrition 0.000 description 7
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 150000001720 carbohydrates Chemical group 0.000 description 6
- 150000002339 glycosphingolipids Chemical class 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 238000006386 neutralization reaction Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000007670 refining Methods 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 229930186217 Glycolipid Natural products 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- 241001133760 Acoelorraphe Species 0.000 description 4
- 239000003225 biodiesel Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000004332 deodorization Methods 0.000 description 4
- 239000000446 fuel Substances 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 238000010626 work up procedure Methods 0.000 description 4
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000221089 Jatropha Species 0.000 description 3
- 240000007228 Mangifera indica Species 0.000 description 3
- 235000014826 Mangifera indica Nutrition 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 244000025272 Persea americana Species 0.000 description 3
- 235000008673 Persea americana Nutrition 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 3
- 239000008157 edible vegetable oil Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000002327 glycerophospholipids Chemical class 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- 240000000058 Argemone mexicana Species 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 240000004355 Borago officinalis Species 0.000 description 2
- 235000007689 Borago officinalis Nutrition 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 235000011331 Brassica Nutrition 0.000 description 2
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 2
- 235000004936 Bromus mango Nutrition 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000009146 Chrysophyllum albidum Nutrition 0.000 description 2
- 244000000755 Chrysophyllum albidum Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000011309 Crambe hispanica subsp abyssinica Nutrition 0.000 description 2
- 241000220247 Crambe hispanica subsp. abyssinica Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical group OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 235000010653 Lupinus angustifolius Nutrition 0.000 description 2
- 240000005776 Lupinus angustifolius Species 0.000 description 2
- 229920000715 Mucilage Polymers 0.000 description 2
- 235000016698 Nigella sativa Nutrition 0.000 description 2
- 244000090896 Nigella sativa Species 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 235000009184 Spondias indica Nutrition 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000021324 borage oil Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 239000010636 coriander oil Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000003869 genetically modified organism Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000010460 hemp oil Substances 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 238000009616 inductively coupled plasma Methods 0.000 description 2
- 150000002506 iron compounds Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 150000008103 phosphatidic acids Chemical class 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- RGTIBVZDHOMOKC-UHFFFAOYSA-N stearolic acid Chemical compound CCCCCCCCC#CCCCCCCCC(O)=O RGTIBVZDHOMOKC-UHFFFAOYSA-N 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000009875 water degumming Methods 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- SBHCLVQMTBWHCD-METXMMQOSA-N (2e,4e,6e,8e,10e)-icosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C(O)=O SBHCLVQMTBWHCD-METXMMQOSA-N 0.000 description 1
- QVSVMNXRLWSNGS-UHFFFAOYSA-N (3-fluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1 QVSVMNXRLWSNGS-UHFFFAOYSA-N 0.000 description 1
- PRHHYVQTPBEDFE-URZBRJKDSA-N (5Z,11Z,14Z)-icosatrienoic acid Chemical compound CCCCC\C=C/C\C=C/CCCC\C=C/CCCC(O)=O PRHHYVQTPBEDFE-URZBRJKDSA-N 0.000 description 1
- DFJAXEWDHVOILU-UHFFFAOYSA-N (5Z,9E)-5,9-Octadecadienoic acid Natural products CCCCCCCCC=CCCC=CCCCC(O)=O DFJAXEWDHVOILU-UHFFFAOYSA-N 0.000 description 1
- HXQHFNIKBKZGRP-URPRIDOGSA-N (5Z,9Z,12Z)-octadecatrienoic acid Chemical compound CCCCC\C=C/C\C=C/CC\C=C/CCCC(O)=O HXQHFNIKBKZGRP-URPRIDOGSA-N 0.000 description 1
- UNSRRHDPHVZAHH-WYTUUNCASA-N (5e,8e,11e)-icosa-5,8,11-trienoic acid Chemical compound CCCCCCCC\C=C\C\C=C\C\C=C\CCCC(O)=O UNSRRHDPHVZAHH-WYTUUNCASA-N 0.000 description 1
- YUFFSWGQGVEMMI-UHFFFAOYSA-N (7Z,10Z,13Z,16Z,19Z)-7,10,13,16,19-docosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCCCC(O)=O YUFFSWGQGVEMMI-UHFFFAOYSA-N 0.000 description 1
- YUFFSWGQGVEMMI-RCHUDCCISA-N (7e,10e,13e,16e,19e)-docosa-7,10,13,16,19-pentaenoic acid Chemical compound CC\C=C\C\C=C\C\C=C\C\C=C\C\C=C\CCCCCC(O)=O YUFFSWGQGVEMMI-RCHUDCCISA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSDMISMEMOGBFU-UHFFFAOYSA-N (all-Z)-7,10,13-Eicosatrienoic acid Natural products CCCCCCC=CCC=CCC=CCCCCCC(O)=O KSDMISMEMOGBFU-UHFFFAOYSA-N 0.000 description 1
- HQPCSDADVLFHHO-UHFFFAOYSA-N (all-Z)-8,11,14,17-Eicosatetraenoic acid Natural products CCC=CCC=CCC=CCC=CCCCCCCC(O)=O HQPCSDADVLFHHO-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- ZCUQOPGIJRGJDA-UHFFFAOYSA-N 1-naphthalen-1-ylethane-1,2-diamine Chemical compound C1=CC=C2C(C(N)CN)=CC=CC2=C1 ZCUQOPGIJRGJDA-UHFFFAOYSA-N 0.000 description 1
- IJKRDVKGCQRKBI-UHFFFAOYSA-N 11,12-methyleneoctadecanoic acid Chemical compound CCCCCCC1CC1CCCCCCCCCC(O)=O IJKRDVKGCQRKBI-UHFFFAOYSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- NGYPZWVLQXBEJM-UHFFFAOYSA-N 2,4-bis(methylsulfanyl)butanoic acid Chemical compound CSCCC(SC)C(O)=O NGYPZWVLQXBEJM-UHFFFAOYSA-N 0.000 description 1
- UFOOFOUFKSIFCD-KTKRTIGZSA-N 2-hydroxynervonic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCC(O)C(O)=O UFOOFOUFKSIFCD-KTKRTIGZSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- RLCKHJSFHOZMDR-PWCSWUJKSA-N 3,7R,11R,15-tetramethyl-hexadecanoic acid Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCCC(C)CC(O)=O RLCKHJSFHOZMDR-PWCSWUJKSA-N 0.000 description 1
- YNCBLMJCJJLPEK-UHFFFAOYSA-N 4,6-bis(methylsulfanyl)hexanoic acid Chemical compound CSCCC(SC)CCC(O)=O YNCBLMJCJJLPEK-UHFFFAOYSA-N 0.000 description 1
- AVKOENOBFIYBSA-GUTOPQIJSA-N 4,7,10,13,16-Docosapentaenoic acid Chemical compound CCCCC\C=C\C\C=C\C\C=C\C\C=C\C\C=C\CCC(O)=O AVKOENOBFIYBSA-GUTOPQIJSA-N 0.000 description 1
- AVKOENOBFIYBSA-UHFFFAOYSA-N 4,7,10,13,16-Docosapentaenoic acid Natural products CCCCCC=CCC=CCC=CCC=CCC=CCCC(O)=O AVKOENOBFIYBSA-UHFFFAOYSA-N 0.000 description 1
- UNSRRHDPHVZAHH-UHFFFAOYSA-N 6beta,11alpha-Dihydroxy-3alpha,5alpha-cyclopregnan-20-on Natural products CCCCCCCCC=CCC=CCC=CCCCC(O)=O UNSRRHDPHVZAHH-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- MUZYOAHCGSIXJH-UHFFFAOYSA-N 8-(2-hexylcyclopropyl)octanoic acid Chemical compound CCCCCCC1CC1CCCCCCCC(O)=O MUZYOAHCGSIXJH-UHFFFAOYSA-N 0.000 description 1
- FBUKMFOXMZRGRB-YFHOEESVSA-N 9(10)-EpOME Chemical compound CCCCC\C=C/CC1OC1CCCCCCCC(O)=O FBUKMFOXMZRGRB-YFHOEESVSA-N 0.000 description 1
- OYHQOLUKZRVURQ-UHFFFAOYSA-N 9,12-Octadecadienoic Acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- 241000440443 Acrocomia Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001536303 Botryococcus braunii Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- 235000016401 Camelina Nutrition 0.000 description 1
- 244000197813 Camelina sativa Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 235000019492 Cashew oil Nutrition 0.000 description 1
- 241000196319 Chlorophyceae Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 235000010206 Corchorus olitorius Nutrition 0.000 description 1
- 244000227473 Corchorus olitorius Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- FBUKMFOXMZRGRB-UHFFFAOYSA-N Coronaric acid Natural products CCCCCC=CCC1OC1CCCCCCCC(O)=O FBUKMFOXMZRGRB-UHFFFAOYSA-N 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 241000195632 Dunaliella tertiolecta Species 0.000 description 1
- 235000013830 Eruca Nutrition 0.000 description 1
- 241000801434 Eruca Species 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 241000362749 Ettlia oleoabundans Species 0.000 description 1
- 241000195619 Euglena gracilis Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000208817 Guizotia Species 0.000 description 1
- 235000003239 Guizotia abyssinica Nutrition 0.000 description 1
- 240000002795 Guizotia abyssinica Species 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 1
- 240000004153 Hibiscus sabdariffa Species 0.000 description 1
- 241001501873 Isochrysis galbana Species 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 241000224476 Nannochloropsis salina Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000019495 Pecan oil Nutrition 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 241000206731 Phaeodactylum Species 0.000 description 1
- 235000019496 Pine nut oil Nutrition 0.000 description 1
- 235000019497 Pistachio oil Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- HXQHFNIKBKZGRP-UHFFFAOYSA-N Ranuncelin-saeure-methylester Natural products CCCCCC=CCC=CCCC=CCCCC(O)=O HXQHFNIKBKZGRP-UHFFFAOYSA-N 0.000 description 1
- 235000001537 Ribes X gardonianum Nutrition 0.000 description 1
- 235000001535 Ribes X utile Nutrition 0.000 description 1
- 235000016919 Ribes petraeum Nutrition 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 235000002355 Ribes spicatum Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- DFJAXEWDHVOILU-KWUOUXIESA-N Taxoleic acid Chemical compound CCCCCCCC\C=C/CC\C=C/CCCC(O)=O DFJAXEWDHVOILU-KWUOUXIESA-N 0.000 description 1
- 241000264606 Tetradesmus dimorphus Species 0.000 description 1
- 241000894100 Tetraselmis chuii Species 0.000 description 1
- 241000405713 Tetraselmis suecica Species 0.000 description 1
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- VENIIVIRETXKSV-BQYQJAHWSA-N Ximenynic acid Chemical compound CCCCCC\C=C\C#CCCCCCCCC(O)=O VENIIVIRETXKSV-BQYQJAHWSA-N 0.000 description 1
- VENIIVIRETXKSV-UHFFFAOYSA-N Xionenynic acid Natural products CCCCCCC=CC#CCCCCCCCC(O)=O VENIIVIRETXKSV-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- WJEIYVAPNMUNIU-UHFFFAOYSA-N [Na].OC(O)=O Chemical compound [Na].OC(O)=O WJEIYVAPNMUNIU-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000010472 acai oil Substances 0.000 description 1
- TWSWSIQAPQLDBP-UHFFFAOYSA-N adrenic acid Natural products CCCCCC=CCC=CCC=CCC=CCCCCCC(O)=O TWSWSIQAPQLDBP-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- HQPCSDADVLFHHO-LTKCOYKYSA-N all-cis-8,11,14,17-icosatetraenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HQPCSDADVLFHHO-LTKCOYKYSA-N 0.000 description 1
- TWSWSIQAPQLDBP-DOFZRALJSA-N all-cis-docosa-7,10,13,16-tetraenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O TWSWSIQAPQLDBP-DOFZRALJSA-N 0.000 description 1
- JIWBIWFOSCKQMA-LTKCOYKYSA-N all-cis-octadeca-6,9,12,15-tetraenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O JIWBIWFOSCKQMA-LTKCOYKYSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- YZXBAPSDXZZRGB-CGRWFSSPSA-N arachidonic acid Chemical compound CCCCC\C=C\C\C=C\C\C=C\C\C=C\CCCC(O)=O YZXBAPSDXZZRGB-CGRWFSSPSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000010480 babassu oil Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000010474 borage seed oil Substances 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000010467 cashew oil Substances 0.000 description 1
- 229940059459 cashew oil Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- MSUOLNSQHLHDAS-UHFFFAOYSA-N cerebronic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)C(O)=O MSUOLNSQHLHDAS-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-N cis-vaccenic acid Chemical compound CCCCCC\C=C/CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-FPLPWBNLSA-N 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- SHMXLCRUTGTGGS-UHFFFAOYSA-N dithiolane-3-carboxylic acid Chemical compound OC(=O)C1CCSS1 SHMXLCRUTGTGGS-UHFFFAOYSA-N 0.000 description 1
- MBMBGCFOFBJSGT-SFGLVEFQSA-N docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C\C\C=C\C\C=C\C\C=C\C\C=C\C\C=C\CCC(O)=O MBMBGCFOFBJSGT-SFGLVEFQSA-N 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- KFEVDPWXEVUUMW-UHFFFAOYSA-N docosanoic acid Natural products CCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 KFEVDPWXEVUUMW-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- MGLDCXPLYOWQRP-UHFFFAOYSA-N eicosa-5,8,11,14-tetraynoic acid Chemical compound CCCCCC#CCC#CCC#CCC#CCCCC(O)=O MGLDCXPLYOWQRP-UHFFFAOYSA-N 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- PRHHYVQTPBEDFE-UHFFFAOYSA-N eicosatrienoic acid Natural products CCCCCC=CCC=CCCCCC=CCCCC(O)=O PRHHYVQTPBEDFE-UHFFFAOYSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000015707 frontal fibrosing alopecia Diseases 0.000 description 1
- LQJBNNIYVWPHFW-QXMHVHEDSA-N gadoleic acid Chemical compound CCCCCCCCCC\C=C/CCCCCCCC(O)=O LQJBNNIYVWPHFW-QXMHVHEDSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- QQHJDPROMQRDLA-UHFFFAOYSA-N hexadecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCC(O)=O QQHJDPROMQRDLA-UHFFFAOYSA-N 0.000 description 1
- 238000007731 hot pressing Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 150000002680 magnesium Chemical class 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- QFUDHWDUKUCCHZ-UHFFFAOYSA-N methyl hydrogen sulfite Chemical compound COS(O)=O QFUDHWDUKUCCHZ-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- YWWVWXASSLXJHU-WAYWQWQTSA-N myristoleic acid Chemical compound CCCC\C=C/CCCCCCCC(O)=O YWWVWXASSLXJHU-WAYWQWQTSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000001711 nigella sativa Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000010470 pecan oil Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 229940067626 phosphatidylinositols Drugs 0.000 description 1
- 239000010490 pine nut oil Substances 0.000 description 1
- 239000010471 pistachio oil Substances 0.000 description 1
- 229940082415 pistachio oil Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000007517 polishing process Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000010491 poppyseed oil Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000009419 refurbishment Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- LGJMUZUPVCAVPU-HRJGVYIJSA-N stigmastanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-HRJGVYIJSA-N 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- GVZXZHWIIXHZOB-UHFFFAOYSA-N tariric acid Chemical compound CCCCCCCCCCCC#CCCCCC(O)=O GVZXZHWIIXHZOB-UHFFFAOYSA-N 0.000 description 1
- GDBJCCBRRCYCEG-UHFFFAOYSA-N tariric acid Natural products CCCCCCCCCCCCC#CCCCC(O)=O GDBJCCBRRCYCEG-UHFFFAOYSA-N 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 1
- 239000010496 thistle oil Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- DXNCZXXFRKPEPY-UHFFFAOYSA-N tridecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCC(O)=O DXNCZXXFRKPEPY-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 239000010913 used oil Substances 0.000 description 1
- 244000045561 useful plants Species 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/006—Refining fats or fatty oils by extraction
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/02—Refining fats or fatty oils by chemical reaction
- C11B3/04—Refining fats or fatty oils by chemical reaction with acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/02—Refining fats or fatty oils by chemical reaction
- C11B3/06—Refining fats or fatty oils by chemical reaction with bases
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/10—Refining fats or fatty oils by adsorption
Definitions
- the present invention relates to a method and an apparatus for the gradual workup of an organic oil.
- An organic oil contains lipid components and various other accompanying substances, the latter reducing the quality of valuable products obtained from the oil and possibly limiting their use.
- the CN 103 396 884 A discloses treating raw rapeseed oil, then adding vinegar, adding deionized water, and finally adding sodium carbonate. All substances are combined in a single step in a mixture.
- the US 4,808,426 A discloses an extraction process when adding foreign oil. A degumming is described in this publication. This is followed by the addition of a binding agent in the form of sodium acetate. The oil is then further treated by adding various other agents, such as soy protein or sodium soap.
- Example I discloses the treatment of degummed oil with sodium carbonate (not sodium hydrogen carbonate).
- Example VI an electrolyte with sodium acetate is used.
- oils are usually subjected to a so-called degumming process for the purpose of technical refining in order to convert hydratable compounds into a water phase, as a result of which the dissolved or aggregated compounds can be separated off using processes for phase separation.
- degumming process for the purpose of technical refining in order to convert hydratable compounds into a water phase, as a result of which the dissolved or aggregated compounds can be separated off using processes for phase separation.
- the majority of hydratable and some non-hydratable phospholipids are separated by these processes.
- This can include, for example, saponification of the free fatty acids.
- Magnesium and / or calcium salts and / or chelates such as chlorophyll, such as chlorophyll, can usually be present in the vegetable oil. However, these are difficult to separate from the free fatty acids and therefore, after the free fatty acids have been separated off, dissolved or undissolved alkaline earth metal salts can be present as accompanying substances in the free fatty acid fraction.
- a method according to the invention relates to the gradual workup of an oil according to claim 1.
- This step-by-step refurbishment can preferably be integrated into an established refining process for producing an edible oil or a fuel for internal combustion engines as a sequence of steps.
- the step-by-step process includes the following steps: A Provision of a crude oil
- the crude oil can be obtained, for example, from plants by pressing or extraction processes. However, a variety of other provision variants are also possible.
- the crude oil does not necessarily have to be obtained directly from living beings, but, as with deep-frying oil, can also have been used as intended once or several times.
- B Deguming the crude oil by adding water and / or acid to the crude oil and forming at least two phases, an aqueous phase and an oil phase, and separating the aqueous phase enriched with phospholipid from the oil phase
- Degumming is a known process step in itself. One differentiates between water degumming and the less frequently used acid degumming. The latter is preferred in the method according to the invention.
- the acid addition can be the addition of a dilute acid or, likewise preferably, the addition of a concentrated acid in connection with a subsequent addition of water.
- Mainly hydratable mucilages such as hydratable phosphoglycerides such as phosphatidylinositols and phosphatidylcholines, are separated from the oil phase and transferred to the aqueous phase. These can be separated centrifugally.
- the addition of sodium hydrogen carbonate has a separation of alkaline earth compounds and / or iron compounds, e.g. also chlorophyll, other magnesium complexes or also calcium complexes or iron complexes.
- iron ions or iron compounds results in a lower susceptibility to oxidation of the oil phase.
- Some of the alkaline earth compounds can be present as phospholipids.
- the addition of sodium hydrogen bicarbonate also removes non-hydratable phospholipids, preferably non-hydratable phosphoglycerides, such as e.g. Phosphatidylethanolaminen and even of phosphatidic acid and its salts, especially their alkali and alkaline earth salts, takes place.
- the separation can preferably be carried out by phase separation of an aqueous and an oil phase in a centrifugal field.
- an organic oil is obtained which, compared to the degummed oil fraction in step B, has a lower proportion of one or more accompanying oils (sterylglycosides, alkaline earth compounds and / or phospholipids), which is usually difficult to obtain from an organic oil separately from the free fatty acids can be.
- the free fatty acid content compared to the oil fraction from step B is surprisingly almost unchanged after step C.
- step D free fatty acids are saponified in step D with the addition of an alkaline agent to the oil phase from step C, whereby these saponified fatty acids can be separated from the oil phase.
- the saponified fatty acids can pass as a relatively pure fraction from the oil phase into a water phase, which is formed by adding water before, during or after the addition of the alkaline agent.
- the saponified fatty acid has less than 3% by weight of organic contaminants. These soaps can then be broken down again under pressure or with the addition of acid to free fatty acids. This reaction is commonly known as soap splitting. Due to the relatively high purity of the soap fraction, there is only a less contaminated water phase during soap splitting. Contaminated soap fractions, on the other hand, would make soap splitting difficult.
- the separation can preferably be carried out by phase separation of an aqueous and an oil phase in the centrifugal field.
- step C or D further refining of the oil phase can also take place in step C or D. This is done through the optional step E Bleaching and / or deodorising the oil phase
- bleaching process can be carried out much more effectively. Bleaching can be carried out particularly effectively, for example, by bleaching earth.
- Deodorization can also be designed effectively. As is known, deodorization can be done mechanically by e.g. by steam distillation in a so-called deodoriser.
- degumming is carried out by adding an acid which is selected from one or more of the following acids: citric acid, acetic acid, formic acid, oxalic acid, hydrochloric acid, sulfuric acid, nitric acid and / or phosphoric acid.
- Organic acids have proven to be particularly suitable for the separation of mucilage from the aforementioned acids.
- step C The addition of sodium hydrogen carbonate after step C can be repeated until the turbidity of the water phase and / or a determined content of alkaline earth metal ions in the oil phase and / or a determined phosphorous content in the oil phase falls below a predetermined target value. Due to the addition as a powder or suspension and comparatively little water, there is no extensive water phase to be worked up. In this way, step C can be carried out several times without the workup becoming uneconomical due to the resulting solvents. At the same time, the quantitatively improved separation of accompanying substances is achieved by the multiple addition.
- an aqueous phase can be separated off which contains a proportion of free fatty acids which corresponds to a separation of less than 0.2 percentage points of free fatty acids from the oil phase.
- step C can preferably be used to separate an aqueous phase in which organic constituents are dissolved or are present in suspension, which contain more than 30% by weight, preferably more than 50% by weight, of steryl glycosides.
- the saponified fatty acid can preferably have less than 1% by weight of organic contaminants.
- the alkaline agent added in step D is an inorganic alkali liquor, preferably a sodium hydroxide solution.
- the addition of this comparatively inexpensive agent is sufficient after separation of sterylglycosides and / or phospholipids and / or alkaline earth metal compounds in order to obtain an oil phase which is predominantly free of accompanying substances.
- Fig. 2 shows a device which has a receptacle 1 for receiving the aqueous phase or the salt solution or a suspension of the salts described herein.
- a line 2 into which a pump 14 is connected
- a container 3 is preferably designed as a constant pressure buffer container.
- the container 3 can have an overflow return 4, which serves to return liquid from the container 2 into the receptacle 1 when an overflow level is exceeded.
- the container 3 also has a drain line 5 (preferably at its lower end), in which a valve 6 is connected here.
- the volume flow in the drain line 5 can be controlled with the valve 6.
- the drain line opens into a mixer 7.
- a further phase, preferably the lipoid-containing (lipid) phase, can be passed through the feed line 8 into the mixer 7.
- the mixer 7 also has an outlet line 9 which opens into an inlet of a centrifuge 10. The two supplied phases are mixed in the mixer 7.
- the mixer 7 can be designed in various ways. So a static mixer or a dynamic mixer can be used. Special shapes such as a high-shear mixer or a nanoreactor are also suitable. It is also conceivable to use the centrifuge itself as a mixer. In this case, the lipoid phase and the salt solution (aqueous solution) passed through separate feed lines into the centrifuge, where - for example in a distributor 15 of the centrifuge drum - these two phases are mixed. Such distributors are known per se and are used to transfer the incoming product into the rotating drum.
- a separator with a vertical axis of rotation which is designed to separate two liquid phases of different densities, is preferably used as the centrifuge.
- the device can also be designed to operate under pressure p which is higher than atmospheric pressure.
- the preferred rule is: 1 bar ⁇ p ⁇ 10 bar.
- the outlet pressure in the outlets 11 and 12 should be higher than the inlet pressure in the inlet to the centrifuge.
- An air inlet in the inlet should preferably be avoided in order to prevent an emulsion from forming to a disruptive extent in the mixer and / or in the centrifuge drum.
- this device prevents the formation of emulsions, which means that on the one hand it is easier to separate fractions containing phospholipids, alkaline earth-containing compounds and / or sterylglycosides, because there is better phase separation and, on the other hand, the depletion of the oil phase is more complete than with a mixing and separation system that does not prevent the exclusion of air / gas entry according to the invention.
- a first step A crude oil, ie the organic oil to be worked up, is made available.
- Main products obtained from the oil can be used, for example, but not exclusively, as fuels or as edible oils. If necessary the obtained valuable products can also be esterified in one processing step to produce biodiesel.
- Preparatory steps can be taken to extract crude oil.
- Starting from plant seeds these can be prepared, e.g. peeled, and then oiled.
- the de-oiling can take place, for example, by means of a pressing process.
- Hot pressing and cold pressing processes are known for the extraction of vegetable oil.
- Extraction processes e.g. hexane extraction can be used.
- crude oil organic oil
- organic oil encompasses mixtures of substances of biological origin which can therefore be obtained from plants, algae, animals and / or microorganisms and which have a water content of ⁇ 10% and a content of lipophilic substances comprising monoacylglycerides , Diacylglycerides and / or triacylglycerides totaling> 70% by weight or> 75% by weight or> 80% by weight or> 85% by weight or> 90% by weight or> 95% by weight .
- the lipoid phases can be extracts of oil-containing plants and microorganisms such as kernels from rapeseed, soybeans, camelina, jatropha, palm trees, but also from algae and microalgae as well as animal fats and oils.
- oil-containing plants and microorganisms such as kernels from rapeseed, soybeans, camelina, jatropha, palm trees, but also from algae and microalgae as well as animal fats and oils.
- An organic oil or a crude oil can be a vegetable oil, for example.
- the crude oil can also be an oil of animal origin.
- the crude oil can also be an already used oil, e.g. Frying fat, act which has already been used and which it is for further use, e.g. as fuel to be processed.
- Many other refined oils are conceivable, which have to be worked up within the scope of the present invention.
- the crude oil may also consist of> 50% organic solvents or hydrocarbon compounds.
- fats and oils are classified in the class of lipids, while the group of lipoids includes all other compounds of the Class waxes, carotenoids, glycolipids, phosphatides, prostaglandins, etc. includes. (Definition after Beyer, Walter, "Textbook of Organic Chemistry” 21st edition S.Hirzel Verlag, 1988 - p.248 )
- oils or fats such as, for example, vegetable oils
- Table 1 summarizes some substance classes found in oils and / or fats that were obtained from various useful plants. It can already be seen here that the neutral lipids usually make up the majority of the oils or fats, but the proportion of phospholipids and glycolipids / glycoglycerolipids / glycosphingolipids is extremely variable.
- the percentage of glycolipids, glycoglycerolipids and glycosphingolipids ranges from 0.2% in coconut oil, over approx. 2% in borage oil and 6.3 - 7% in rice bran oil to 19.4% in oil from avocado seeds.
- Tab. 1 Content of lipids without ionic groups (NL), phospholipids (PL) and glycolipids together with glycoglycerolipids and glycosphingolipids (GL) in the seeds (S) or the oils obtained from selected plants.
- the PL and GL content is given as a percentage of the total oil. In the case of seeds, it is also sometimes stated how high the percentage of oil (total) is compared to the seed mass.
- Crude oils as defined herein include Acai oil, acrocomia oil, almond oil, babassu oil, currant seed oil, borage seed oil, rapeseed oil, cashew oil, castor oil, coconut oil, coriander oil, corn oil, cottonseed oil, crab oil, linseed oil, grape seed oil, hazelnut oil, other nut oil oils, hemp seed oil, hemp seed oil , Jojoba oil, macadamia nut oil, mango kernel oil, cuckoo oil, mustard oil, claw oil, olive oil, palm oil, palm kernel oil, palm olein oil, peanut oil, pecan oil, pine nut oil, pistachio oil, poppy seed oil, rice germ oil, thistle oil, camellia oil, sesame oil, sheab oil , Soybean oil, sunflower oil, tall oil, tsubaki oil, walnut oil, varieties of "natural” oils with modified fatty acid compositions via genetically modified organisms (GMOs) or traditional breeds, Neoch
- a crude oil phase and a solid phase are obtained.
- the solids of the solid phase can be processed further, for example to isolate or enrich feed, fiber, proteins, polyphenols or other valuable substances.
- Glycerin sterylglycosides
- the free fatty acids phospholipids, tocopherol and other substances.
- These are preferably present in the crude oil at a content of less than 400 ppm, preferably less than 100 ppm.
- Phospholipids are separated. These are phosphorus-containing organic substances that have the properties of a fat. A distinction is made between phospholipids in non-hydratable phospholipids (NHP) and hydratable phospholipids (HP). Hydratable phospholipids are, for example, phosphatidylinositol or its salts, phosphatidylcholine. Non-hydratable phospholipids are, for example, phosphatidylethanolamine and phosphatidic acid or salts thereof. Typical cations of the phospholipids are e.g. Sodium, potassium, calcium, etc.
- hydratable phospholipids and / or non-hydratable phospholipids which can easily be converted into a hydratable form, are first separated off.
- water is added to the crude oil and phospholipids, if they can be hydrated, are hydrated. These phospholipids accumulate as sludge and can be centrifugally separated from the oil.
- Non-hydratable phospholipids can be destroyed by heating, by adding certain adsorbents, by filtration and / or by adding an acid as a complex and thereby converted into a hydratable form.
- the addition of acid is called acid degumming, while the exclusive addition of water is known as water degumming.
- water degumming After degumming, a degummed oil fraction is obtained, which however still has a residual proportion of phospholipids, in particular non-hydratable phospholipids (see section 3.1).
- An acidic aqueous phase which contains, for example, citric acid, acetic acid, formic acid and / or oxalic acid can advantageously be used for acid degumming.
- hydrochloric acid, sulfuric acid, nitric acid and / or phosphoric acid can be used less preferably.
- Fig. 6 shows clearly and exemplarily the classification of the phospholipids in non-hydratable and hydratable phospholipids. (NHP's and HP's). In acidic processes, PE can easily be converted into a hydratable form by protonating the amino group as shown in the figure.
- a third step III of the oil processing sodium hydrogen carbonate is added. It has surprisingly been found that when sodium hydrogen carbonate is added, additional separation of remaining phospholipids, in particular non-hydratable phospholipids, in particular phosphatidic acid compounds, such as e.g. dissolved salts.
- a separation of a proportion of sterylglycosides also takes place when sodium bicarbonate is added, which are separated from the degummed oil fraction.
- the proportion of calcium, magnesium and possibly also iron ions is greatly reduced, since these are displaced by the addition of sodium ions in the form of sodium hydrogen carbonate.
- the free fatty acids remain almost completely in the oil phase.
- fatty acids is used synonymously with the term “free fatty acids”.
- free is intended to clarify that the fatty acids are not bound because the majority of the constituents in the nonpolar oil phase contain bound fatty acids, e.g. as triacylglycerides, diacylglycerides or monoacylglycerides.
- Aliphatic monocarboxylic acids with at least 8 carbon atoms are referred to as fatty acids.
- fatty acids refers to free fatty acids (also abbreviated to FFAs), i.e. fatty acids which are free and are not glyceridically (i.e. to glycerol) or glycosidically (i.e. to sugar residues) bound.
- fatty acids preferably includes the following compounds: hexanoic acid, octanoic acid, decanoic acid, dodecanoic acid, tetradecanoic acid, hexadecanoic acid, heptadecanoic acid, octadecanoic acid, eicosanoic acid, docosanoic acid, tetracosanoic acid, cis-9-tetradecenoic acid, cis-9-hexadecenoic acid, cis-9-cenadecenoic acid , cis-9-octadecenoic acid, cis-11-octadecenoic acid, cis-9-eicosenoic acid, cis-11-eicosenoic acid, cis-13-docosenoic acid, cis-15-tetracosenoic acid, t9-octadecenoic acid, t11-
- free fatty acids can easily form oxidative compounds. To ensure the durability of refined oil and oil derivatives, these free fatty acids should therefore be removed from the processed oil phase. This takes place in a fourth step D in which the worked-up oil phase is mixed with an alkaline agent.
- an alkaline agent It is an inorganic alkali lye, i.e. a sodium hydroxide or a potassium hydroxide solution, the use of sodium hydroxide solution having proven to be particularly efficient and inexpensive.
- This lye separates the free fatty acids as accompanying substances from the oil phase.
- the free fatty acids are saponified and can be recovered in a very high degree of purity by separating both phospholipids and unwanted cations (alkaline earth metal ions and iron ions).
- soap splitting e.g. by adding acid
- the free fatty acids can be extracted from the soaps.
- the fourth step by adding an alkaline agent, separates a fraction of a comparatively pure fatty acid as soap.
- the phosphorus content in the worked-up oil phase can be reduced to a content of less than 3 ppm, preferably even less than 1 ppm, since portions of NHPs are removed more easily after step 3 with the soap.
- the main product ie the oils and fats, is refined further by bleaching and / or deodorising.
- Bleaching earth can predominantly be used as an agent in bleaching, which can be used more efficiently in the present process. It is also possible to add the bleaching earth at the same time as the sodium hydrogen carbonate or sodium acetate. Deodorization can be carried out, for example, by steam distillation in a so-called deodoriser. In this way, for example, undesirable odorous substances can be removed from the oil
- Further steps in the refining process of the oil and / or fat can optionally also take place before or after the bleaching and / or deodorization. These include, for example, oil polishing and / or drying under vacuum to remove water components.
- sodium acetate can also be added instead of the sodium bicarbonate. It has surprisingly been found that when sodium acetate is added there is an additional enrichment of sterylglycosides in the aqueous phase which are separated from the degummed oil fraction. At the same time residual phospholipids, free fatty acids and alkaline earth compounds, e.g. Chlorophyll remains predominantly or almost completely in the oil phase.
- the steryl glycosides are sterols which are glycosidically linked to at least one saccharide residue via a hydroxyl group.
- Sterylglycosides are found in plants, animals, fungi and also in some bacteria. In animals, for example, there is cholesterol glucoronide, in which a cholesterol residue is linked to a glucuronic acid residue.
- the sterol residue is preferably campesterol, stigmasterol, sitosterol, brassicasterol or dihydrositosterol and the saccharide residue is preferably glucose, galactose, Mannose, glucuronic acid, xylose, rhamnose or arabinose.
- the saccharide residue in plant steryl glycosides is linked to the sterol via the hydroxy group on the C3 of the A ring of the sterol. Further saccharide residues can be linked to this first saccharide residue via a ⁇ -1,4-glycosidic bond or a ⁇ -1,6-glycosidic bond.
- acylated sterylglycosides (ASGs) in which a saccharide residue at its hydroxyl group at position 6 is esterified with a fatty acid. In many plants, acylated sterylglycosides were found in practically all parts of the plant in up to 0.125% by weight.
- the proportion of non-acylated and acylated steryl glycosides in palm and soybean oil is particularly high.
- a high proportion of steryl glycosides is discussed in connection with poorer filterability.
- An oil phase remains in which the sterylglycoside content has already been significantly reduced, which facilitates further processing.
- a phase can be separated by adding an alkaline agent.
- the proportion of sterylglycoside in the water phase is relatively high, ie at least over 60% by weight, preferably over 80% by weight, compared to the proportion of sterylglycoside in the oil phase.
- the sterylglycosides obtained can be used in cosmetic and / or pharmaceutical products.
- a fourth step D in which the worked-up oil phase is mixed with an alkaline agent, the separation into non-polar oil phase and polar aqueous soap phase takes place.
- This is preferably an alkali liquor, that is to say a sodium hydroxide or a potassium hydroxide solution, the use of sodium hydroxide solution also having proven particularly preferred in this case.
- This lye separates the free fatty acids, as well as the remaining phospholipids and alkaline earth species, including chlorophyll, as accompanying substances in an aqueous phase from the oil phase.
- the free fatty acids are saponified and can optionally be recovered by subsequent soap splitting.
- Crude oil (FFA content 0.48% by weight, H 2 O content 0.05% by weight, iron content 1.13 ppm, phosphorus content 80.42 ppm, magnesium content 8.47 ppm, calcium content 45 , 10 ppm) is filled into the storage tank (storage tank 1) as press oil from a rapeseed.
- the crude oil in the storage tank 1 is then heated to 85 ° C. and then 0.1% by weight of dilute citric acid (33% by weight, to room temperature) is added and the mixture is stirred vigorously for 30 seconds and then at about 10 minutes Stirred 100 to 150 rpm. Then 0.6% by weight of water is added.
- the mixture of oil and dilute citric acid is then pumped into the separation separator and then the aqueous phase B is separated from the oily phase A at a rate of 200 l / h.
- the aqueous phase A is collected and stored until further use.
- the oily phase A is transferred to a further storage tank (storage tank 2) for further processing.
- the oily phase A is then analyzed (FFA content 0.48% by weight, H 2 O content 0.23% by weight, iron content 0.34 ppm, phosphorus content 26.1 ppm, magnesium content 2 , 32 ppm, calcium content 9.04 ppm).
- the oily phase A obtained in this way is brought to a process temperature of 45 ° C. and a sufficient volume of 8% by weight sodium hydrogen carbonate solution is added so that a theoretical degree of neutralization of the free fatty acids of 90% is achieved.
- a sufficient volume of sodium hydrogen carbonate can be chosen such that more than 0.1% by weight NaHCO 3 , based on the weight of the oil phase used, for example 0.3% by weight NaHCO 3, is added.
- the addition need not necessarily be made as a solution, but can also be done as a powder. Water can then be added separately.
- the mixture is stirred intensively for 30 seconds but without the entry of air, ie without the introduction of gas, and then for 10 minutes normally but still without the entry of air, ie without the introduction of gas.
- the resulting mixture is then in the separation separator pumped and thus separated the aqueous phase B from the oily phase A at a rate of 200 l / h.
- the aqueous phase B is collected. In this, sterylglycosides were detected by TLC.
- the oily phase A is transferred back to the storage tank 1 for further processing.
- the oily phase is then analyzed (FFA content 0.32% by weight, H 2 O content 0.23% by weight, iron content 0.15 ppm, phosphorus content 5.75 ppm, magnesium content 0. 69 ppm, calcium content 3.46 ppm).
- Crude oil (FFA content 0.43% by weight, H 2 O content 0.05% by weight, iron content 0.60 ppm, phosphorus content 52.52 ppm, magnesium content 5.43 ppm, calcium content 31 , 33 ppm) is filled into the storage tank (storage tank 1) as press oil from a rapeseed.
- the crude oil in the storage tank 1 is then heated to 85 ° C. and then 0.1% by weight of citric acid (33%, to room temperature) is added and the mixture is stirred vigorously for 30 seconds and then stirred at about 100 to 150 rpm for 10 minutes. Then 0.6% by weight of water is added.
- the mixture of crude oil and dilute citric acid is then pumped into the separation separator and then the aqueous phase B is separated from the oily phase A at a rate of 200 l / h.
- the aqueous phase A is collected and stored until further use.
- the oily phase A is transferred to a further storage tank (storage tank 2) for further processing.
- the oily phase A is then analyzed (FFA content 0.43% by weight, H 2 O content 0.26% by weight, iron content 0.17 ppm, phosphorus content 12.49 ppm, magnesium content 0 , 40 ppm, calcium content 1.85 ppm).
- the oily phase A obtained in this way is brought to a process temperature of 45 ° C. and a sufficient volume of 8% sodium acetate solution is added so that a degree of neutralization of the free fatty acids of 90% is achieved.
- the mixture is then stirred intensively and preferably free of gas for 30 seconds using a Ystral mixer and then stirred normally and preferably for 10 minutes without gas.
- the resulting mixture is then pumped into the separation separator and thus the aqueous phase B is separated from the oily phase A at a rate of 200 l / h.
- aqueous phase B sterylglycosides were detected using TLC.
- the oily phase A is transferred back to the storage tank 1 for further processing.
- the oily phase A is analyzed (FFA content 0.43% by weight, H 2 O content 0.24% by weight, iron content 0.09 ppm, phosphorus content 5.79 ppm, magnesium content 0.25 ppm, calcium content 0.89 ppm).
- Crude oil (FFA content 0.54%, H 2 O content 0.05%, iron content 0.53 ppm, phosphorus content 78.32 ppm, magnesium content 5.70 ppm, calcium content 33.04 ppm) is filled into the storage tank (storage tank 1) as press oil from a rapeseed.
- the crude oil in the storage tank 1 is then heated to approx. 85 ° C. and then 0.1% by weight of citric acid (33%, at room temperature) is added and the mixture is stirred intensively for 30 seconds and then at about 100 to 150 rpm for 10 minutes touched. Then 0.6% by weight of water is added.
- the mixture of crude oil and dilute citric acid is then pumped into the separation separator and then the aqueous phase B is separated from the oily phase A at a rate of 200 l / h.
- the aqueous phase A is collected and stored until further use.
- the oily phase B is transferred to another storage tank (storage tank 2) for further processing.
- the oily phase A is then analyzed (FFA content 0.48% by weight, H 2 O content 0.53% by weight, iron content 0.15 ppm, phosphorus content 16.57 ppm, magnesium content 0 , 28 ppm, calcium content 1.78 ppm).
- the oily phase A obtained in this way is brought to a process temperature of 40-45 ° C. and a sufficient volume of 8% sodium carbonate solution is added so that a theoretical degree of neutralization of the free fatty acids of 90% is achieved.
- the mixture is then stirred intensively and preferably free of gas for 30 seconds using a Ystral mixer and then stirred normally for 10 minutes, preferably free of gas.
- the resulting mixture is then pumped into the separation separator and thus the aqueous phase B is separated from the oily phase A at a rate of 200 l / h.
- aqueous phase B sterylglycosides were detected using TLC.
- the oily phase A is transferred back to the storage tank 1 for further processing.
- the oily phase A is analyzed (FFA content 0.25% by weight, H 2 O content 0.49% by weight, iron content 0.15 ppm, phosphorus content 2.21 ppm, magnesium content 0, 07 ppm, calcium content 0.32 ppm).
- Examples 1 and 2 are subsequently produced by adding a sufficient amount of 12% NaOH solution in a so-called oil polishing process worked up.
- the oil phase is separated from saponified free fatty acids. It can then be bleached and deodorized.
- Fig. 3 shows on the basis of experimentally determined data that the addition of a sodium hydrogen carbonate solution in step C reduces the phosphorus content in the oil phase. This reduced phosphorus content goes hand in hand with the reduction of phospholipids in the oil phase.
- Fig. 4 also shows that the proportion of free fatty acids is not reduced when sodium hydrogen carbonate is added. In comparison, you can see in Fig. 4 that there is a reduction in fatty acids in the oil phase when sodium carbonate is added.
- Crude oil A1 was treated with aqueous citric acid solution (33%, addition: 1000 ppm) at 85 ° C. and mixed with a shaving head mixer for 30 seconds. After a reaction time of 10 minutes, a sample was taken and the oil phase A2 was measured.
- Fig. 5a shows an exemplary sequence of process steps B and C, as well as the optional process step D.
- citric acid is first added as an aqueous solution. This reduces the phosphorus content and thus the proportion of phospholipids in the oil phase.
- the aqueous phase r 1 is separated from the oil phase.
- a portion of sodium bicarbonate is added to the oil phase as a solution, suspension or as a powder - preferably in the case of powder addition with subsequent water addition. This leads to a further reduction in phospholipids in the oil phase.
- the aqueous phase r 2 is separated from the oil phase. Further phospholipids can then be separated off in optional step D.
- the concentration of phospholipids in the oil phase can, however, be very low, so that they can hardly be taken into account in relation to the fatty acids.
- the limit Z between the two steps can thus be chosen variably. And depends, among other things, on the desired targets for the purity of the FFA phase.
- the molar masses of KOH and oleic acid can be used to directly calculate the free fatty acid content in mass percent in the fat / oil.
- the direct and quantitative determination of the elements phosphorus, calcium, magnesium and iron in the oil samples is carried out by means of Inductively Coupled Plasma - Emission Spectral Analysis (ICP).
- ICP Inductively Coupled Plasma - Emission Spectral Analysis
- the sample material atomized into an aerosol is injected into the hot core of an argon plasma. At a temperature of more than 8000K, the sample material is atomized and simultaneously excited. It can be analyzed qualitatively and quantitatively for trace elements in the emission spectrum.
- the HLB value was determined in the aqueous phases and in the oil phases of the respective process steps.
- the analysis is carried out with an Asahipak GF-310 HQ multiple solvent GPC column. This enables ionic and non-ionic surfactants to be differentiated and classified according to their HLB value.
- a DC method thin layer chromatography was used to detect the respective accompanying substances, for example sterylglycosides.
- the thin layer chromatography was carried out with silica gel G plates. The separation takes place with a mixture of chloroform / acetone / water (30/60/2).
- the development was carried out with a naphthyl ethylenediamine reagent, which allows sugar residues of the oil accompanying substances to be displayed in color.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL15727638T PL3152283T3 (pl) | 2014-06-05 | 2015-06-03 | Sposób i urządzenie do stopniowego przetwarzania oleju organicznego |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102014107976 | 2014-06-05 | ||
PCT/EP2015/062434 WO2015185657A1 (de) | 2014-06-05 | 2015-06-03 | Verfahren und vorrichtung zur schrittweisen aufarbeitung eines organischen öls |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3152283A1 EP3152283A1 (de) | 2017-04-12 |
EP3152283B1 true EP3152283B1 (de) | 2020-08-05 |
Family
ID=53366022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15727638.7A Active EP3152283B1 (de) | 2014-06-05 | 2015-06-03 | Verfahren und vorrichtung zur schrittweisen aufarbeitung eines organischen öls |
Country Status (12)
Country | Link |
---|---|
US (1) | US10214705B2 (da) |
EP (1) | EP3152283B1 (da) |
JP (1) | JP6574837B2 (da) |
CN (1) | CN106459828A (da) |
BR (1) | BR112016027964B1 (da) |
CA (1) | CA2950806C (da) |
DK (1) | DK3152283T3 (da) |
ES (1) | ES2829643T3 (da) |
MY (1) | MY177293A (da) |
PL (1) | PL3152283T3 (da) |
RU (1) | RU2016150076A (da) |
WO (1) | WO2015185657A1 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3098293A1 (en) | 2015-05-27 | 2016-11-30 | Evonik Degussa GmbH | A process for removing metal from a metal-containing glyceride oil comprising a basic quaternary ammonium salt treatment |
EP3098292A1 (en) | 2015-05-27 | 2016-11-30 | Evonik Degussa GmbH | A process for refining glyceride oil comprising a basic quaternary ammonium salt treatment |
GB2538758A (en) | 2015-05-27 | 2016-11-30 | Green Lizard Tech Ltd | Process for removing chloropropanols and/or glycidol |
DE102015212749A1 (de) | 2015-07-08 | 2017-01-12 | Evonik Degussa Gmbh | Verfahren zur Entfeuchtung von feuchten Gasgemischen |
DE102016210484A1 (de) | 2016-06-14 | 2017-12-14 | Evonik Degussa Gmbh | Verfahren zur Entfeuchtung von feuchten Gasgemischen |
EP3257568B1 (de) | 2016-06-14 | 2019-09-18 | Evonik Degussa GmbH | Verfahren zur entfeuchtung von feuchten gasgemischen mit ionischen flüssigkeiten |
DE102016210478A1 (de) | 2016-06-14 | 2017-12-14 | Evonik Degussa Gmbh | Verfahren zur Entfeuchtung von feuchten Gasgemischen |
BR112019024641B1 (pt) | 2017-05-24 | 2023-01-10 | Poet Research, Inc | Método para alterar uma ou mais propriedades do asfalto, composição de mistura de asfalto e composição de mistura de aglutinante de asfalto |
WO2019092013A1 (de) | 2017-11-10 | 2019-05-16 | Evonik Degussa Gmbh | Verfahren zur extraktion von fettsäuren aus triglyceridölen |
EP3483237A1 (de) | 2017-11-10 | 2019-05-15 | Evonik Degussa GmbH | Verfahren zur extraktion von fettsäuren aus triglyceridölen |
WO2019092017A1 (de) | 2017-11-10 | 2019-05-16 | Evonik Degussa Gmbh | Verfahren zur extraktion von fettsäuren aus triglyceridölen |
US10711221B2 (en) | 2018-02-09 | 2020-07-14 | Poet Research, Inc. | Method of refining a grain oil composition to make one or more grain oil products, and related systems |
CA3103242C (en) | 2018-06-11 | 2023-08-29 | Poet Research, Inc. | Methods of refining a grain oil composition feedstock, and related systems, compositions and uses |
FI128504B (en) | 2018-12-14 | 2020-06-30 | Upm Kymmene Corp | A process for purifying a renewable feed comprising triglycerides |
KR102395099B1 (ko) * | 2019-08-02 | 2022-05-13 | 주식회사 청담 | 탈산 장치 및 이를 이용하는 탈산유 제조 방법 |
WO2022032011A1 (en) | 2020-08-06 | 2022-02-10 | Poet Research, Inc. | Endogenous lipase for metal reduction in distillers corn oil |
KR102639682B1 (ko) * | 2021-04-07 | 2024-02-22 | 농업회사법인 크레이지피넛 주식회사 | 땅콩오일 정제방법 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2752378A (en) * | 1952-10-25 | 1956-06-26 | Glidden Co | Hydration method of refining glyceride oils |
US4160774A (en) * | 1978-01-25 | 1979-07-10 | Cadbury India Limited | Process of degumming fatty glycerides using sodium acetate and acetic acid buffer |
JPS54120609A (en) * | 1978-03-14 | 1979-09-19 | Hohnen Oil Co Ltd | Preparation of oil for cooking on hot plate |
JPS60248798A (ja) * | 1984-05-23 | 1985-12-09 | ミヨシ油脂株式会社 | 油脂の脱酸脱色方法 |
US4808426A (en) * | 1986-04-23 | 1989-02-28 | Epe Incorporated | Vegetable oil extraction process |
US5315021A (en) * | 1992-07-01 | 1994-05-24 | The Procter & Gamble Company | Process for removing chlorophyll color impurities from vegetable oils |
US6197357B1 (en) | 1998-05-28 | 2001-03-06 | University Of Massachusetts | Refined vegetable oils and extracts thereof |
CN102191127B (zh) * | 2011-04-20 | 2012-11-21 | 陕西省动物研究所 | 一种简便的水貂油精制方法 |
CN102504946B (zh) * | 2011-11-04 | 2013-09-04 | 福建春辉生物工程有限公司 | 一种对三高人群有益的油茶籽毛油精炼方法 |
CN103396880A (zh) * | 2013-07-23 | 2013-11-20 | 怀宁县小市植物油厂 | 一种炒籽菜籽油及其制备方法 |
CN103396884A (zh) * | 2013-07-23 | 2013-11-20 | 怀宁县小市植物油厂 | 一种菜籽油及其制备方法 |
CN103382411B (zh) * | 2013-07-26 | 2015-06-24 | 怀宁县小市植物油厂 | 一种低温压榨复配菜籽油的生产工艺 |
CN103509648A (zh) * | 2013-07-31 | 2014-01-15 | 安徽省霍山县聚一科技有限公司 | 一种山茶油的精制脱脂方法 |
DE102014210662A1 (de) | 2014-06-04 | 2015-12-17 | Gea Westfalia Separator Group Gmbh | Vorrichtung und Verfahren zur Gewinnung von Glycoglycerolipiden und Glycosphingolipiden aus lipoiden Phasen |
-
2015
- 2015-06-03 RU RU2016150076A patent/RU2016150076A/ru not_active Application Discontinuation
- 2015-06-03 WO PCT/EP2015/062434 patent/WO2015185657A1/de active Application Filing
- 2015-06-03 JP JP2017516197A patent/JP6574837B2/ja active Active
- 2015-06-03 MY MYPI2016704502A patent/MY177293A/en unknown
- 2015-06-03 ES ES15727638T patent/ES2829643T3/es active Active
- 2015-06-03 US US15/315,897 patent/US10214705B2/en active Active
- 2015-06-03 PL PL15727638T patent/PL3152283T3/pl unknown
- 2015-06-03 EP EP15727638.7A patent/EP3152283B1/de active Active
- 2015-06-03 CN CN201580033299.3A patent/CN106459828A/zh active Pending
- 2015-06-03 DK DK15727638.7T patent/DK3152283T3/da active
- 2015-06-03 BR BR112016027964-6A patent/BR112016027964B1/pt active IP Right Grant
- 2015-06-03 CA CA2950806A patent/CA2950806C/en active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
ES2829643T3 (es) | 2021-06-01 |
BR112016027964A2 (pt) | 2017-08-22 |
CN106459828A (zh) | 2017-02-22 |
RU2016150076A (ru) | 2018-07-09 |
DK3152283T3 (da) | 2020-11-02 |
JP6574837B2 (ja) | 2019-09-11 |
PL3152283T3 (pl) | 2021-02-08 |
JP2017519892A (ja) | 2017-07-20 |
EP3152283A1 (de) | 2017-04-12 |
US10214705B2 (en) | 2019-02-26 |
BR112016027964B1 (pt) | 2021-11-30 |
CA2950806C (en) | 2021-12-28 |
MY177293A (en) | 2020-09-11 |
CA2950806A1 (en) | 2015-12-10 |
US20170107449A1 (en) | 2017-04-20 |
RU2016150076A3 (da) | 2018-09-21 |
WO2015185657A1 (de) | 2015-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3152283B1 (de) | Verfahren und vorrichtung zur schrittweisen aufarbeitung eines organischen öls | |
DE69711374T3 (de) | Verfahren zum extrahieren von sterol mit einem polaren lösungsmittel zur herstellung eines mikrobiellen öles mit niedrigem sterolgehalt | |
EP1828361B1 (de) | Verfahren zur herstellung eines rohöls aus gemischen von mikroorganismen und pflanzen, das so hergestellte öl sowie die spezifischen verwendungen des so hergestellten und gegebenenfalls zusätzlich raffinierten öls | |
EP1838171B1 (de) | Herstellung und anwendung eines antioxidativ wirksamen extraktes aus crypthecodinium sp | |
DE69403958T2 (de) | Unverseifbare materialien pflanzlichen ursprungs und diese enthaltende kosmetische präparate | |
WO2015185516A1 (de) | Verfahren und vorrichtungen zur emulsionsspaltung und zur komplexierung von organischen verbindungen in emulsionen | |
EP2334773A1 (de) | Verfahren zur isolierung von ölen aus zellen und biomasse | |
EP3148345A1 (de) | Verfahren zum raffinieren von lipidphasen und verwendung | |
EP3152219B1 (de) | Verfahren zur gewinnung von glycoglycerolipiden und glycosphingolipiden aus lipoiden phasen | |
DE69111048T2 (de) | Verfahren zum extrahieren von nebenfettverbindungen aus einer substanz biologischer herkunft. | |
WO2015181399A1 (de) | Verfahren zur veredelung raffinierter lipidphasen | |
EP2311929A1 (de) | Verfahren zur Aufarbeitung von leicht verseifbarem Rohöl pflanzlicher oder tierischer Herkunft, für die Weiterverarbeitung zu Biodiesel | |
DE2147327A1 (de) | Verfahren zur Trennung von Phos phatiden aus Phosphaüdmischungen | |
WO2009003710A1 (de) | Verfahren zur schonenden raffination von pflanzenölen mit naturbleicherde | |
EP1500695B1 (de) | Verwendung eines Verfahrens zur Aufbereitung von glycosidhaltigen Pflanzenölen, um genießbare und lagerfähige Pflanzenöle zu bereiten. | |
DE2551342B2 (de) | Verfahren zur gewinnung von lipiden aus kartoffeln | |
DE68916630T2 (de) | Lipidzusammensetzung mit genügender sicherheit und starker oberflächenwirkung. | |
WO2014096024A1 (de) | Verfahren zur herstellung einer lipid-reichen zusammensetzung aus mikroorganismen | |
WO2015185676A1 (de) | Vorrichtung und verfahren zur gewinnung von glycoglycerolipiden und glycosphingolipiden aus lipoiden phasen | |
DE102017220041A1 (de) | Verfahren zur Extraktion von Chlorid aus Triglyceridölen | |
DE102017220045A1 (de) | Verfahren zur Extraktion von 3-Chlor-1,2-Propandiol aus Triglyceridölen | |
DE2921499A1 (de) | Verfahren zur herstellung mehrerer nahrungsmittelfraktionen aus natuerlichen fetten, wie z.b. oelen oder fetten und insbesondere palmoel | |
DE1042363B (de) | Verfahren zur Stabilisierung von Fetten und OElen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20161207 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180507 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20200310 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1298726 Country of ref document: AT Kind code of ref document: T Effective date: 20200815 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502015013174 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20201030 |
|
REG | Reference to a national code |
Ref country code: FI Ref legal event code: FGE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201207 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201105 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201105 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201106 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201205 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502015013174 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2829643 Country of ref document: ES Kind code of ref document: T3 Effective date: 20210601 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 |
|
26N | No opposition filed |
Effective date: 20210507 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20210603 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210603 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210630 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210603 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210603 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20150603 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230413 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20230627 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20230703 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20240625 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20240627 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20240626 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240626 Year of fee payment: 10 Ref country code: FI Payment date: 20240626 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20240529 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20240626 Year of fee payment: 10 Ref country code: BE Payment date: 20240625 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200805 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240627 Year of fee payment: 10 |